Neuromod startup IVEAcare raises $27.5M, names CEO
Minneapolis-based neuromodulation technology developer iVEAcare announced today that it raised $27.5 million in a Series A financing round.
Source: massdevice.com
Treo Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Treo Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Treo Ventures Today - Breaking & Trending Today
iVEAcare Raises $27.5M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders Forum in San Francisco
SAN FRANCISCO, Calif., Oct. 25, 2022 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present
Source: athensreview.com
Neuspera Medical appoints new CEO
Implantable neuromodulation technology developer Neuspera Medical announced today that Steffen Hovard joined the company as CEO.
Source: massdevice.com
Neuspera Medical Closes $65M Series C Equity Financing
Neuspera Medical Inc., a San Jose, Calif.-based clinical stage, private venture capital backed neuromodulation company, closed a $65m series C equity financing. The round was co-led by Vertex Ventures HC and Treo Ventures with participation from returning Series A and Series B investors Action Potential Venture Capital and Windham Venture Partners. In conjunction with the funding, Lori Hu, a Managing Director at Vertex Ventures HC and Mudit K. Jain, Ph.D. Managing Partner, Treo Ventures, joined the Board of Directors. The company intends to use the funds to conduct the SANS-UUI pivota...
Source: finsmes.com